Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Polymer-based sirolimus- (Cypher) and paclitaxel-eluting (Taxus) drug eluting stents have become the treatment of choice for patients with symptomatic coronary artery disease undergoing percutaneous coronary intervention (PCI). Although these stents reduce rates of restenosis compared with bare metal stents (BMS), late thrombosis, a life threatening complication, has emerged as a major safety concern. Our understanding of the pathophysiology of late DES thrombosis is derived from animal and human pathologic samples taken after implantation of these devices. These data indicate that both DES cause substantial impairment in arterial healing characterized by lack of complete reendothelialization and persistence of fibrin when compared with BMS. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy. Several additional risk factors for late stent thrombosis such as penetration of necrotic core, malapposition, overlapping stent placement, excessive stent length, and bifurcation lesions represent additional barriers to healing and should be avoided if DES are to be used to minimize the risk of late thrombosis. Because the time course of complete healing with DES in man is unknown, the optimal duration of antiplatelet treatment remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Iakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Self-citationDaemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
Stone, G. W., Moses, J. W., Ellis, S. G., Schofer, J., Dawkins, K. D., Morice, M.-C., Colombo, A., Schampaert, E., Grube, E., Kirtane, A. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067193 · Cited by 1,631
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Self-citationStent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
Mauri, L., Hsieh, W.-H., Massaro, J. M., Ho, K. K. L., D'Agostino, R., & Cutlip, D. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067731 · Cited by 1,441
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
McFadden, E. P., Stabile, E., Regar, E., Cheneau, E., Ong, A. T., Kinnaird, T., Suddath, W. O., Weissman, N. J., Torguson, R., Kent, K. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17275-9 · Cited by 1,436
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Cited by
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
Joner, M., Nakazawa, G., Finn, A. V., Quee, S. C., Coleman, L., Acampado, E., Wilson, P. S., Skorija, K., Cheng, Q., Xu, X., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.030 · Cited by 641
Self-citationNakazawa, G., Finn, A. V., Joner, M., Ladich, E., Kutys, R., Mont, E. K., Gold, H. K., Burke, A. P., Kolodgie, F. D., & Virmani, R. (2008) · Circulation · doi:10.1161/circulationaha.107.762047 · Cited by 611
Self-citationByrne, R. A., Joner, M., & Kastrati, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv511 · Cited by 609
Self-citationVascular Inflammation and Repair
Inoue, T., Croce, K., Morooka, T., Sakuma, M., Node, K., & Simon, D. I. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.05.025 · Cited by 480
Onuma, Y., & Serruys, P. W. (2011) · Circulation · doi:10.1161/circulationaha.110.971606 · Cited by 434
Stefanini, G. G., Byrne, R. A., Serruys, P. W., de Waha, A., Meier, B., Massberg, S., Juni, P., Schomig, A., Windecker, S., & Kastrati, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs086 · Cited by 384
Räber, L., Magro, M., Stefanini, G. G., Kalesan, B., van Domburg, R. T., Onuma, Y., Wenaweser, P., Daemen, J., Meier, B., Jüni, P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.058560 · Cited by 374
Holmes, D. R., Kereiakes, D. J., Garg, S., Serruys, P. W., Dehmer, G. J., Ellis, S. G., Williams, D. O., Kimura, T., & Moliterno, D. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.016 · Cited by 367
Kang, S.-J., Mintz, G. S., Akasaka, T., Park, D.-W., Lee, J.-Y., Kim, W.-J., Lee, S.-W., Kim, Y.-H., Whan Lee, C., Park, S.-W., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.988436 · Cited by 359
Stefanini, G. G., Kalesan, B., Serruys, P. W., Heg, D., Buszman, P., Linke, A., Ischinger, T., Klauss, V., Eberli, F., Wijns, W., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61672-3 · Cited by 354
Tada, T., Byrne, R. A., Simunovic, I., King, L. A., Cassese, S., Joner, M., Fusaro, M., Schneider, S., Schulz, S., Ibrahim, T., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.06.015 · Cited by 342
Self-citationBiological responses in stented arteries
Chaabane, C., Otsuka, F., Virmani, R., & Bochaton-Piallat, M.-L. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt115 · Cited by 335
Self-citationSerruys, P. W., Farooq, V., Kalesan, B., de Vries, T., Buszman, P., Linke, A., Ischinger, T., Klauss, V., Eberli, F., Wijns, W., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.04.011 · Cited by 331
Stettler, C., Allemann, S., Wandel, S., Kastrati, A., Morice, M. C., Schomig, A., Pfisterer, M. E., Stone, G. W., Leon, M. B., Lezo, J. S. D., et al. (2008) · BMJ · doi:10.1136/bmj.a1331 · Cited by 320
“which may explain the predisposition of people with diabetes to this adverse event in the absence of adequate antiplatelet therapy. In necropsy studies, drug eluting stents delayed arterial healing and re-endothelialisation compared with bare metal stents.”
BackgroundGarg, S., & Serruys, P. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.008 · Cited by 306
Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo
Yoo, H., Kim, J. W., Shishkov, M., Namati, E., Morse, T., Shubochkin, R., McCarthy, J. R., Ntziachristos, V., Bouma, B. E., Jaffer, F. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2555 · Cited by 303
Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment
Abou Sherif, S., Ozden Tok, O., Taşköylü, Ö., Goktekin, O., & Kilic, I. D. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00024 · Cited by 286
Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease
Wiebe, J., Nef, H. M., & Hamm, C. W. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.041 · Cited by 255
Luo, R., Tang, L., Zhong, S., Yang, Z., Wang, J., Weng, Y., Tu, Q., Jiang, C., & Huang, N. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am3027635 · Cited by 212
Impact of polymer hydrophilicity on biocompatibility: Implication for DES polymer design
Hezi‐Yamit, A., Sullivan, C., Wong, J., David, L., Chen, M., Cheng, P., Shumaker, D., Wilcox, J. N., & Udipi, K. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32057 · Cited by 165
Metadata
- Authors
- Finn, A. V., Nakazawa, G., Joner, M., Kolodgie, F. D., Mont, E. K., Gold, H. K., & Virmani, R.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2007-07
- Volume
- 27
- Issue
- 7
- Pages
- 1500-1510
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2119470649
- Cited by
- 900
- References
- 47
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.